Literature DB >> 12393134

Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder.

Yehuda Senecky1, Danielle Lobel, Gary W Diamond, Raphael Weitz, Dov Inbar.   

Abstract

We report a case of orofacial dyskinesia in a 6-year-old female with attention-deficit-hyperactivity disorder who received a low dose of methylphenidate. The orofacial dyskinesia appeared immediately and subsided rapidly on the same day in an "on-off" fashion and on 3 separate days when methylphenidate was taken. To our knowledge this particular side effect has not been described previously and might represent an unusual type of brain response or sensitivity.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12393134     DOI： 10.1016/s0887-8994(02)00429-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


  7 in total

1.  Abnormal movements are associated with poor psychosocial functioning in adolescents at high risk for psychosis.

Authors:  Vijay A Mittal; Maria Jalbrzikowski; Melita Daley; Cristina Roman; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2011-06-01       Impact factor: 4.939

2.  Methylphenidate-induced akathisia in a patient with multiple sclerosis.

Authors:  Maria S Almeida; Prasad R Padala; Subhash Bhatia
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

3.  Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.

Authors:  Presenters Ornella Potter; Nadyah John; Discussant Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-10       Impact factor: 2.576

4.  Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period.

Authors:  Vijay A Mittal; Elaine F Walker; Carrie E Bearden; Deborah Walder; Hanan Trottman; Melita Daley; Anthony Simone; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2010-03-15       Impact factor: 13.382

5.  Neurological adverse effects of methylphenidate may be misdiagnosed as meningoencephalitis.

Authors:  Luke Blagdon Snell; Dinkar Bakshi
Journal:  BMJ Case Rep       Date:  2015-06-16

6.  Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents.

Authors:  Mohamed Mohamoud; Qi Chen; David Croteau; Carmen Cheng; Keith Burkhart; Donna A Volpe; Cindy Kortepeter; Dorothy Demczar; Marc Stone
Journal:  J Clin Psychopharmacol       Date:  2022 May-Jun 01       Impact factor: 3.118

Review 7.  Psychostimulants and movement disorders.

Authors:  Andres Asser; Pille Taba
Journal:  Front Neurol       Date:  2015-04-20       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.